Literature DB >> 23651103

Metabolic syndrome predicts all-cause mortality in persons with human immunodeficiency virus.

Olamide D Jarrett1, Christine A Wanke, Robin Ruthazer, Ioana Bica, Rita Isaac, Tamsin A Knox.   

Abstract

We examined the association between metabolic syndrome (MS) and its individual defining criteria on all-cause mortality in human immunodeficiency virus (HIV)-infected persons. We used data from 567 HIV-infected participants of the Nutrition for Healthy Living study with study visits between 9/1/2000 and 1/31/2004 and determined mortality through 12/31/2006. MS was defined using modified National Cholesterol Education Program guidelines. Cox proportional hazards for all-cause mortality were estimated for baseline MS status and for its individual defining criteria. There were 83 deaths with median follow-up of 63 months. Baseline characteristics associated with increased risk of mortality were: older age in years (univariate hazard ratio [HR] 1.04, p<0.01), current smoking (HR 1.99, p=0.02), current heroin use (HR 1.97, p=0.02), living in poverty (HR 2.0, p<0.01), higher mean HIV viral load (HR 1.81, p<0.01), and having a BMI <18 (HR 5.84, p<0.01). For MS and its criteria, only low HDL was associated with increased risk of mortality on univariate analysis (HR 1.84, p=0.01). However, metabolic syndrome (adjusted HR 2.31, p=0.02) and high triglycerides (adjusted HR 3.97, p<0.01) were significantly associated with mortality beyond 36 months follow-up. MS, low HDL, and high triglycerides are associated with an increased risk of mortality in HIV-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23651103      PMCID: PMC3651687          DOI: 10.1089/apc.2012.0402

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  31 in total

Review 1.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

2.  Markers for HIV-disease progression in untreated patients and patients receiving AZT: evaluation of viral activity, AZT resistance, serum cholesterol, beta 2-microglobulin, CD4+ cell counts, and HIV antigen.

Authors:  H Rübsamen-Waigmann; B Schröder; L Biesert; C D Bauermeister; H von Briesen; H Suhartono; F Zimmermann; H D Brede; A Regeniter; S Gerte
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 3.  The role of the cytokines, interferon alpha and tumor necrosis factor in the hypertriglyceridemia and wasting of AIDs.

Authors:  C Grunfeld; K R Feingold
Journal:  J Nutr       Date:  1992-03       Impact factor: 4.798

4.  Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.

Authors:  Shaista Malik; Nathan D Wong; Stanley S Franklin; Tripthi V Kamath; Gilbert J L'Italien; Jose R Pio; G Rhys Williams
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

5.  National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.

Authors:  Kelly J Hunt; Roy G Resendez; Ken Williams; Steve M Haffner; Michael P Stern
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

6.  C-reactive protein is an independent predictor of mortality in women with HIV-1 infection.

Authors:  Joseph G Feldman; Philip Goldwasser; Susan Holman; Jack DeHovitz; Howard Minkoff
Journal:  J Acquir Immune Defic Syndr       Date:  2003-02-01       Impact factor: 3.731

7.  The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study.

Authors:  Earl S Ford
Journal:  Atherosclerosis       Date:  2004-04       Impact factor: 5.162

8.  Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection.

Authors:  Gail Shor-Posner; Abdul Basit; Ying Lu; Claudio Cabrejos; Jeani Chang; Maryann Fletcher; Emilio Mantero-Atienza; Marianna K Baum
Journal:  Am J Med       Date:  1993-05       Impact factor: 4.965

9.  Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions.

Authors:  J R McNamara; E J Schaefer
Journal:  Clin Chim Acta       Date:  1987-06-30       Impact factor: 3.786

10.  Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men.

Authors:  Peter T Katzmarzyk; Timothy S Church; Steven N Blair
Journal:  Arch Intern Med       Date:  2004-05-24
View more
  9 in total

1.  Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.

Authors:  Lesley S Park; Raúl U Hernández-Ramírez; Michael J Silverberg; Kristina Crothers; Robert Dubrow
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

Review 2.  Metabolic syndrome, diabetes, and cardiovascular risk in HIV.

Authors:  Linda M Nix; Phyllis C Tien
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

3.  Metabolic syndrome in relation to cardiorespiratory fitness, active and sedentary behavior in HIV+ Hispanics with and without lipodystrophy.

Authors:  Farah A Ramírez-Marrero; Jorge L Santana-Bagur; Michael J Joyner; Jorge Rodríguez-Zayas; Walter Frontera
Journal:  P R Health Sci J       Date:  2014-12       Impact factor: 0.705

4.  Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on Statins.

Authors:  Martin Krsak; David M Kent; Norma Terrin; Christina Holcroft; Sally C Skinner; Christine Wanke
Journal:  AIDS Patient Care STDS       Date:  2015-04-09       Impact factor: 5.078

5.  Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIV.

Authors:  Win Min Han; Matthew G Law; Jun Yong Choi; Rossana Ditangco; Nagalingeswaran Kumarasamy; Romanee Chaiwarith; Penh Sun Ly; Suwimon Khusuwan; Tuti Parwati Merati; Cuong Duy Do; Evy Yunihastuti; Iskandar Azwa; Man-Po Lee; Thach Ngoc Pham; Yu-Jiun Chan; Sasisopin Kiertiburanakul; Oon Tek Ng; Junko Tanuma; Sanjay Pujari; Fujie Zhang; Yasmin Gani; Vidya Mave; Jeremy Ross; Anchalee Avihingsanon
Journal:  HIV Med       Date:  2021-11-23       Impact factor: 3.180

6.  Life Instability Associated with Lower ART Adherence and Other Poor HIV-Related Care Outcomes in Older Adults with HIV.

Authors:  Elliott R Weinstein; Audrey Harkness; Gail Ironson; Cho-Hee Shrader; Dustin T Duncan; Steven A Safren
Journal:  Int J Behav Med       Date:  2022-05-02

Review 7.  Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV.

Authors:  Raquel Martin-Iguacel; Eugènia Negredo; Robert Peck; Nina Friis-Møller
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

8.  Food insecurity and other poverty indicators among people living with HIV/AIDS: effects on treatment and health outcomes.

Authors:  Seth C Kalichman; Dominica Hernandez; Chauncey Cherry; Moira O Kalichman; Christopher Washington; Tamar Grebler
Journal:  J Community Health       Date:  2014-12

Review 9.  Prevalence of cardiometabolic syndrome in HIV-infected persons: a systematic review.

Authors:  Minyahil Woldu; Omary Minzi; Ephrem Engidawork
Journal:  J Diabetes Metab Disord       Date:  2020-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.